Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine (ERIEAS)
11. oktober 2022 oppdatert av: University Hospital, Bordeaux
The study is a realistic evaluation of the Expériences Animées school-based programme.
The aim is to precisely characterize i) the effects in terms of alcohol and cannabis consumption, the use of health professionals in case of problematic use of those two substances; ii) the context and underpinning mechanisms triggered by the program in terms of changes of alcohol and cannabis representations and life skills development.
This evaluation could allow to produce the key functions of the programme: how the intervention works, in which conditions.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
- Alcohol consumption represents the second main modifiable risk factor for cancer and the second preventable mortality cause in France, after tobacco use. It is mainly during adolescence, which corresponds to a period of integration with peers and a period of detachment from parents, that alcohol use starts. In France, alcohol remains the substance that adolescents most experiment with. A 2014 report shows that nearly half (49.4%) of first-year secondary school pupils have already tried an alcoholic drink and about one in seven secondary school pupils' reports having been drunk. The impact of cannabis consumption is wide as it can affect the social environment, the brain and the psychology of the consumers. Adolescence is a period during which the brain undergoes profound remodelling in areas that are high in cannabinoid receptors and that mediate cognitive control and emotion regulation. Therefore, childhood and adolescence are important stages of life on which preventive efforts may be focused, also because events occurring in the earliest stages of human development (before birth and during childhood) are known to be related to further risk for cancer, other chronic diseases and adult conditions.
- Among addiction prevention programmes, those that focus on life skills have been mentioned in the literature as being effective. In this context, the French organization "Association Ressources et Initiatives Addictions" (ARIA) has developed Expériences Animées programme (animated experiences) based on the above features, with the aim to help adolescents to change their representations and strengthen their life skills. This is a grassroots innovation. It has to be evaluated.
- The Expériences Animées programme involves supervised short movies and talks with secondary and high school pupils about the use of psychoactive substances. The movies are made specifically for the programme. The sessions are facilitated by two professionals including at least a clinical psychologist. In a given secondary/high school, one session per term is delivered for each class (40 classes). Three to five films are shown at each session. Each film aims to work on 2 to 3 life skills allowing to build protective behaviors against addictions. This programme is implemented since 2015.
- The investigators will collect quantitative and qualitative data to appraise the outcomes (O), mechanisms (M) and contextual elements (C), including the interventional elements) in order to verify the initial theories (hypothesis of causal pathways) by i) Questionnaires to collect outcomes in terms of consumption and health care, and some mechanisms: 2/ Non-directive interviews to collect mechanisms and contextual factors 3/ Observations to collect contextual elements during the sessions. The investigators will design the survey instruments in line with the initial middle-range theories identified.
Studietype
Observasjonsmessig
Registrering (Faktiske)
1026
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Bordeaux, Frankrike, 33000
- CIC1401-EC - CHU de Bordeaux Centre Inserm U1219
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Prøvetakingsmetode
Ikke-sannsynlighetsprøve
Studiepopulasjon
Pupils from 10 secondary and hugh schools in the department of Charente (France)
Beskrivelse
Inclusion Criteria:
Pupils :
- Pupils from the 10 secondary and high schools selected in the department of Charente, in 2nd and 5th years in 2019/2020 academic year,
- Pupils not opposite to participate and holders of parental authority not opposite to the participation of the child (no later than the day of inclusion)
Others :
- Non-opposition to participate of 3 Education professionals per establishment in the 10 secondary and high schools selected in the department of Charente,
- Non-opposition to participate of 2 session leaders,
- Non-opposition to participate of 3 funders.
Exclusion Criteria:
- Participants under legal protection
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: Annen
- Tidsperspektiver: Potensielle
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Expériences Animées Programme
The Expériences Animées programme involves supervised short movies and talks with secondary school and high school pupils about the use of psychoactive substances.
|
The questionnaires are completed at the 3 survey times (T0, T1 and T2) by all pupils involved.
Collected data are quantitative
The interviews are conducted with 80 pupils/year randomly selected (i.e. 2 per class and 8 per establishment/year).
Collected data are qualitative
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Daily, alcohol consumption
Tidsramme: 3 years
|
Alcohol consumption per day at study entry, after 1 year and after 2 years
|
3 years
|
|
Weekly, alcohol consumption
Tidsramme: 3 years
|
Alcohol consumption per week at study entry, after 1 year and after 2 years
|
3 years
|
|
Monthly, alcohol consumption
Tidsramme: 3 years
|
Alcohol consumption per month at study entry, after 1 year and after 2 years
|
3 years
|
|
Number of episodes of heavy drinking
Tidsramme: 3 years
|
An episode of heavy drinking : at least 5 drinks per occasion at study entry, after 1 year and after 2 years
|
3 years
|
|
Number of drunkenness episodes
Tidsramme: 3 years
|
Number of episodes at study entry, after 1 year and after 2 years
|
3 years
|
|
Weekly, cannabis consumption
Tidsramme: 3 years
|
Number of cannabis consumption per week at study entry, after 1 year and after 2 years
|
3 years
|
|
Monthly, cannabis consumption
Tidsramme: 3 years
|
Number of cannabis consumption per month at study entry, after 1 year and after 2 years
|
3 years
|
|
Yearly, cannabis consumption
Tidsramme: 3 years
|
Number of cannabis consumption per year at study entry, after 1 year and after 2 years
|
3 years
|
|
Number of consultation of a healthcare professional to discuss about a problematic use of alcohol and/or cannabis
Tidsramme: 3 years
|
Number of times at study entry, after 1 year and after 2 years
|
3 years
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: François ALLA, MD PhD, CIC1401-EC, Inserm-CHU de Bordeaux
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
30. september 2019
Primær fullføring (Faktiske)
16. juni 2022
Studiet fullført (Faktiske)
16. juni 2022
Datoer for studieregistrering
Først innsendt
26. september 2019
Først innsendt som oppfylte QC-kriteriene
27. september 2019
Først lagt ut (Faktiske)
1. oktober 2019
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
12. oktober 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
11. oktober 2022
Sist bekreftet
1. oktober 2022
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CHUBX 2018/75
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .